<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36248863</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: A Brazilian study.</ArticleTitle><Pagination><StartPage>1006076</StartPage><MedlinePgn>1006076</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1006076</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1006076</ELocationID><Abstract><AbstractText Label="BACKGROUND">The global burden of persistent COVID-19 in hemodialysis (HD) patients is a worrisome scenario worth of investigation for the critical care of chronic kidney disease (CKD). We performed an exploratory <i>post-hoc</i> study from the trial U1111-1237-8231 with two specific aims: i) to investigate the prevalence of COVID-19 infection and long COVID symptoms from our Cohort of 178 Brazilians HD patients. ii) to identify whether baseline characteristics should predict long COVID in this sample.</AbstractText><AbstractText Label="METHODS">247 community-dwelling older (&gt;60 years) patients (Men and women) undergoing HD (glomerular filtration rate <i>&lt;</i> 15 mL/min/1.73m<sup>2</sup>) with arteriovenous fistula volunteered for this study. All patients presented hypertension and diabetes. Patients were divided in two groups: without long-COVID and with long-COVID. Body composition, handgrip strength, functional performance, iron metabolism, phosphate, and inflammatory profile were assessed. Patients were screened for 11-months after COVID-19 infection. Results were considered significant at <i>P</i> &lt; 0.05.</AbstractText><AbstractText Label="RESULTS">We found that more than 85% of the COVID-19 infected patients presented a severe condition during the infection. In our sample, the mortality rate over 11-month follow was relatively low (8.4%) when compared to worldwide (approximately 36%). Long COVID was highly prevalent in COVID-19 survivors representing more than 80% of all cases. Phosphate and IL-10 were higher in the long COVID group, but only phosphate higher than 5.35 mg/dL appears to present an increased prevalence of long COVID, dyspnea, and fatigue.</AbstractText><AbstractText Label="CONCLUSION">There was a high prevalence of COVID-19 infection and long COVID in HD patients from the Brazilian trial 'U1111-1237-8231'. HD clinics should be aware with phosphate range in HD patients as a possible target for adverse post-COVID events.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Corr&#xea;a, Deus, Ara&#xfa;jo, Reis, Amorim, Gadelha, Santos, Honorato, Motta-Santos, Tzanno-Martins, Neves and Rosa.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corr&#xea;a</LastName><ForeName>Hugo L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deus</LastName><ForeName>Lysleine A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ara&#xfa;jo</LastName><ForeName>Tha&#xed;s B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reis</LastName><ForeName>Andrea L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amorim</LastName><ForeName>Carlos E N</ForeName><Initials>CEN</Initials><AffiliationInfo><Affiliation>Physical Education Department, Federal University of Maranh&#xe3;o, Maranh&#xe3;o, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gadelha</LastName><ForeName>Andr&#xe9; B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servi&#xe7;o de Prepara&#xe7;&#xe3;o F&#xed;sica/COPSA/COSAU/DIGEP/SA/SG/Presid&#xea;ncia da Rep&#xfa;blica, Bras&#xed;lia, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Se&#xe7;&#xe3;o de Educa&#xe7;&#xe3;o F&#xed;sica do Col&#xe9;gio Militar de Bras&#xed;lia, Bras&#xed;lia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Rafael L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honorato</LastName><ForeName>Fernando S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta-Santos</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pontifical Catholic University of Minas Gerais and Sports Department, EEFFTO, UFMG, Belo, Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzanno-Martins</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Group Home Dialysis Center and RenalClass, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neves</LastName><ForeName>Rodrigo V P</ForeName><Initials>RVP</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Thiago S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Physical Education, Catholic University of Bras&#xed;lia, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010710">Phosphates</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010710" MajorTopicYN="N">Phosphates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hemodialysis</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">nephrology</Keyword><Keyword MajorTopicYN="N">phosphate</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36248863</ArticleId><ArticleId IdType="pmc">PMC9562993</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1006076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, et al. . Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study. Lancet Glob Health (2020) 8:e1003&#x2013;17. doi: 10.1016/S2214-109X(20)30264-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30264-3</ArticleId><ArticleId IdType="pmc">PMC7295519</ArticleId><ArticleId IdType="pubmed">32553130</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (2020) 395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature (2020) 584:430&#x2013;6. doi: 10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q. Mortality in chronic kidney disease patients with COVID-19: A systematic review and meta-analysis. Int Urol Nephrol (2021) 53:1623&#x2013;9. doi: 10.1007/s11255-020-02740-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-020-02740-3</ArticleId><ArticleId IdType="pmc">PMC7778685</ArticleId><ArticleId IdType="pubmed">33389508</ArticleId></ArticleIdList></Reference><Reference><Citation>Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, et al. . Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis (2021) 77:190&#x2013;203.e191. doi: 10.1053/j.ajkd.2020.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7501875</ArticleId><ArticleId IdType="pubmed">32961244</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Liao C, He H, Hu C, Wei Z, Hong Z, et al. . COVID-19 in hemodialysis patients: A report of 5 cases. Am J Kidney Dis (2020) 76:141&#x2013;3. doi: 10.1053/j.ajkd.2020.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.03.009</ArticleId><ArticleId IdType="pmc">PMC7118604</ArticleId><ArticleId IdType="pubmed">32240718</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriazo S, Mas-Fontao S, Seghers C, Cano J, Goma E, Avello A, et al. . Increased 1-year mortality in haemodialysis patients with COVID-19: A prospective, observational study. Clin Kidney J (2022) 15:432&#x2013;41. doi: 10.1093/ckj/sfab248</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfab248</ArticleId><ArticleId IdType="pmc">PMC8755355</ArticleId><ArticleId IdType="pubmed">35198156</ArticleId></ArticleIdList></Reference><Reference><Citation>Demiray A, Kanbay A, Kanbay M. Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely? Clin Kidney J (2022) 15:369&#x2013;71. doi: 10.1093/ckj/sfab265</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfab265</ArticleId><ArticleId IdType="pmc">PMC8689791</ArticleId><ArticleId IdType="pubmed">35198153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz A, Cozzolino M, Fliser D, Fouque D, Goumenos D, Massy ZA, et al. . Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant (2021) 36:87&#x2013;94. doi: 10.1093/ndt/gfaa314</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfaa314</ArticleId><ArticleId IdType="pmc">PMC7771976</ArticleId><ArticleId IdType="pubmed">33340043</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz MM, Arias &#xc1;., Mata-V&#xe1;zquez E, Mart&#xed;n-Toledano M, L&#xf3;pez-Larramona G, Ruiz-Chicote AM, et al. . Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med (2021) 10:1&#x2013;15. doi: 10.3390/jcm10132945</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Och A, Tylicki P, Polewska K, Puchalska-Regli&#x144;ska E, Parczewska A, Szabat K, et al. . Persistent post-COVID-19 syndrome in hemodialyzed patients-a longitudinal cohort study from the north of Poland. J Clin Med (2021) 10:1&#x2013;10. doi: 10.3390/jcm10194451</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194451</ArticleId><ArticleId IdType="pmc">PMC8509624</ArticleId><ArticleId IdType="pubmed">34640471</ArticleId></ArticleIdList></Reference><Reference><Citation>Willi S, L&#xfc;thold R, Hunt A, H&#xe4;nggi NV, Sejdiu D, Scaff C, et al. . COVID-19 sequelae in adults aged less than 50 years: A systematic review. Travel Med Infect Dis (2021) 40:101995. doi: 10.1016/j.tmaid.2021.101995</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2021.101995</ArticleId><ArticleId IdType="pmc">PMC7898978</ArticleId><ArticleId IdType="pubmed">33631340</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: Summary of NICE, SIGN, and RCGP rapid guideline. Bmj (2021) 372:n136. doi: 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk S, Turgutalp K, Arici M, Gorgulu N, Tonbul HZ, Eren N, et al. . The longitudinal evolution of post-COVID-19 outcomes among hemodialysis patients in Turkey. Kidney Int Rep (2022) 7, 1393&#x2013;1405. doi: 10.1016/j.ekir.2022.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2022.03.017</ArticleId><ArticleId IdType="pmc">PMC8949692</ArticleId><ArticleId IdType="pubmed">35350104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadelha AB, Cesari M, Corr&#xea;a HL, Neves RVP, Sousa CV, Deus LA, et al. . Effects of pre-dialysis resistance training on sarcopenia, inflammatory profile, and anemia biomarkers in older community-dwelling patients with chronic kidney disease: a randomized controlled trial. Int Urol Nephrol (2021) 53:2137&#x2013;47. doi: 10.1007/s11255-021-02799-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-021-02799-6</ArticleId><ArticleId IdType="pubmed">33609277</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves RVP, Corr&#xea;a HL, Deus LA, Reis AL, Souza MK, Sim&#xf5;es HG, et al. . Dynamic not isometric training blunts osteo-renal disease and improves the sclerostin/FGF23/Klotho axis in maintenance hemodialysis patients: a randomized clinical trial. J Appl Physiol (1985) (2021) 130:508&#x2013;16. doi: 10.1152/japplphysiol.00416.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00416.2020</ArticleId><ArticleId IdType="pubmed">33242299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Handb Surg Am (1984) 9:222&#x2013;6. doi: 10.1016/S0363-5023(84)80146-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0363-5023(84)80146-X</ArticleId><ArticleId IdType="pubmed">6715829</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a HL, Rosa TDS, Dutra MT, Sales MM, Noll M, Deus LA, et al. . Association between dynapenic abdominal obesity and inflammatory profile in diabetic older community-dwelling patients with end-stage renal disease. Exp Gerontol (2021) 146:111243. doi: 10.1016/j.exger.2021.111243</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2021.111243</ArticleId><ArticleId IdType="pubmed">33460716</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca Corr&#xea;a H, Neves RVP, Deus LA, Reis AL, Raab ATO, Rodrigues-Silva PL, et al. . MicroRNA levels in hemodialysis patients following resistance training: Associations with functional performance, inflammatory profile, sestrins-2, and nitric oxide. Exp Gerontol (2022) 162:111761. doi: 10.1016/j.exger.2022.111761</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2022.111761</ArticleId><ArticleId IdType="pubmed">35240260</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al. . A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci (2021) 426:117486. doi: 10.1016/j.jns.2021.117486</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, et al. . Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Renal Physiol (2014) 306:F1418&#x2013;1428. doi: 10.1152/ajprenal.00633.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00633.2013</ArticleId><ArticleId IdType="pubmed">24808541</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue X, Ma J, Zhao Y, Zhao A, Liu X, Guo W, et al. . Correlation between hypophosphatemia and the severity of corona virus disease 2019 patients. MedRxiv. (2020). doi: 10.1101/2020.03.27.20040816</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.27.20040816</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kempen T, Deixler E. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin d, on energy (ATP) metabolism and on severity of COVID-19. Am J Physiol Endocrinol Metab (2021) 320:E2&#x2013;e6. doi: 10.1152/ajpendo.00474.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00474.2020</ArticleId><ArticleId IdType="pmc">PMC7816430</ArticleId><ArticleId IdType="pubmed">33174766</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, He M, Kang Y. Hypophosphatemia at admission is associated with increased mortality in COVID-19 patients. Int J Gen Med (2021) 14:5313&#x2013;22. doi: 10.2147/IJGM.S319717</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S319717</ArticleId><ArticleId IdType="pmc">PMC8435477</ArticleId><ArticleId IdType="pubmed">34526806</ArticleId></ArticleIdList></Reference><Reference><Citation>Javdani F, Parsa S, Shakeri H, Hatami N, Kalani N, Haghbeen M, et al. . Phosphate levels and pulmonary damage in COVID-19 patients based on CO-RADS scheme: Is there any link between parathyroid gland and COVID-19? MedRxiv. (2020). doi: 10.1101/2020.08.25.20181453</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.25.20181453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuro OM. The klotho proteins in health and disease. Nat Rev Nephrol (2019) 15:27&#x2013;44. doi: 10.1038/s41581-018-0078-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-018-0078-3</ArticleId><ArticleId IdType="pubmed">30455427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuro-O M. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol (2013) 9:650&#x2013;60. doi: 10.1038/nrneph.2013.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.111</ArticleId><ArticleId IdType="pubmed">23774819</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcgovern AP, De Lusignan S, Van Vlymen J, Liyanage H, Tomson CR, Gallagher H, et al. . Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: A large community based cohort study. PloS One (2013) 8:e74996. doi: 10.1371/journal.pone.0074996</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074996</ArticleId><ArticleId IdType="pmc">PMC3769279</ArticleId><ArticleId IdType="pubmed">24040373</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, et al. . Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol (2009) 20:381&#x2013;7. doi: 10.1681/ASN.2008040349</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2008040349</ArticleId><ArticleId IdType="pmc">PMC2637048</ArticleId><ArticleId IdType="pubmed">19073826</ArticleId></ArticleIdList></Reference><Reference><Citation>Malieckal DA, Uppal NN, Ng JH, Jhaveri KD, Hirsch JS. Electrolyte abnormalities in patients hospitalized with COVID-19. Clin Kidney J (2021) 14:1704&#x2013;7. doi: 10.1093/ckj/sfab060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfab060</ArticleId><ArticleId IdType="pmc">PMC7989524</ArticleId><ArticleId IdType="pubmed">34079619</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaba H, Fukagawa M. Phosphate-A poison for humans? Kidney Int (2016) 90:753&#x2013;63. doi: 10.1016/j.kint.2016.03.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2016.03.039</ArticleId><ArticleId IdType="pubmed">27282935</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med (2020) 383:2255&#x2013;73. doi: 10.1056/NEJMra2026131</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R, Kanneganti TD. The &#x2018;cytokine storm&#x2019;: Molecular mechanisms and therapeutic prospects. Trends Immunol (2021) 42:681&#x2013;705. doi: 10.1016/j.it.2021.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2021.06.001</ArticleId><ArticleId IdType="pmc">PMC9310545</ArticleId><ArticleId IdType="pubmed">34217595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Zhang H, Zhan M, Jiang J, Yin H, Dauphars DJ, et al. . Preventing mortality in COVID-19 patients: Which cytokine to target in a raging storm? Front Cell Dev Biol (2020) 8:677. doi: 10.3389/fcell.2020.00677</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00677</ArticleId><ArticleId IdType="pmc">PMC7379422</ArticleId><ArticleId IdType="pubmed">32766256</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Zhang H, Dauphars DJ, He YW. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol (2021) 42:3&#x2013;5. doi: 10.1016/j.it.2020.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7605819</ArticleId><ArticleId IdType="pubmed">33214057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>